Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C29H33ClFNO4.H2O.H2O4S |
Molecular Weight | 1144.15 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.OS(O)(=O)=O.C[C@@H](OC[C@H](O)CNC(C)(C)CC1=CC(F)=C(Cl)C=C1)C2=C(C=CC=C2)C3=CC=C(C(O)=O)C(C)=C3.C[C@@H](OC[C@H](O)CNC(C)(C)CC4=CC(F)=C(Cl)C=C4)C5=C(C=CC=C5)C6=CC=C(C(O)=O)C(C)=C6
InChI
InChIKey=NOJBHZIZNPMQRT-CBASKZFISA-N
InChI=1S/2C29H33ClFNO4.H2O4S.H2O/c2*1-18-13-21(10-11-23(18)28(34)35)25-8-6-5-7-24(25)19(2)36-17-22(33)16-32-29(3,4)15-20-9-12-26(30)27(31)14-20;1-5(2,3)4;/h2*5-14,19,22,32-33H,15-17H2,1-4H3,(H,34,35);(H2,1,2,3,4);1H2/t2*19-,22-;;/m11../s1
Encaleret (JTT-305 or MK-5442) is a potent oral short-acting calcium-sensing receptor (CaSR) antagonist and transiently stimulates endogenous parathyroid hormone (PTH) secretion.
CaSR antagonists stimulate endogenous PTH secretion through CaSR on the surface of parathyroid cells and thereby may be anabolic agents for osteoporosis. Japan Tobacco and Merck were developing encaleret for the treatment of osteoporosis however development has been discontinued.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Antagonist for calcium-sensing receptor. JTT-305/MK-5442]. | 2011 Jan |
|
Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats. | 2012 Jun |
|
A semimechanistic model of the time-course of release of PTH into plasma following administration of the calcilytic JTT-305/MK-5442 in humans. | 2013 Aug |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
782120
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
XX-159
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
PRIMARY | |||
|
1214922-52-7
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL1672973
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
PRIMARY | |||
|
C167017
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
PRIMARY | |||
|
51049993
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
PRIMARY | |||
|
100000175006
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
PRIMARY | |||
|
7CKZ1Y8K70
Created by
admin on Fri Dec 15 18:20:14 GMT 2023 , Edited by admin on Fri Dec 15 18:20:14 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD